Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Our cells get stressed too! Implications for human disease.

Michael B Kastan1

  • 1Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. Michael.kastan@stjude.org

Blood Cells, Molecules & Diseases
|June 1, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhanced Response to Radiopharmaceutical Therapy in Preclinical Tumor Models with XRD-0394, a Dual Inhibitor of ATM Kinase and DNA-PKcs.

Radiation research·2026
Same author

ATM interaction with GRP94 modulates oncogenic receptor expression and signaling and microglial activation.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

A Novel Dual ATM/DNA-PK Inhibitor, XRD-0394, Potently Radiosensitizes and Potentiates PARP and Topoisomerase I Inhibitors.

Molecular cancer therapeutics·2024
Same author

Participation of ATM, SMG1, and DDX5 in a DNA Damage-Induced Alternative Splicing Pathway.

Radiation research·2023
Same author

ATM Regulation of the Cohesin Complex Is Required for Repression of DNA Replication and Transcription in the Vicinity of DNA Double-Strand Breaks.

Molecular cancer research : MCR·2022
Same author

DNA-Damage-Induced Alternative Splicing of p53.

Cancers·2021
Same journal

Compound heterozygous variants in F7 gene causing severe factor VII deficiency without bleeding: A genotypic and laboratory analysis.

Blood cells, molecules & diseases·2026
Same journal

Propofol attenuates H<sub>2</sub>O<sub>2</sub>-induced senescence in human umbilical vein endothelial cells by activating the NRF2/HO-1 axis.

Blood cells, molecules & diseases·2026
Same journal

Is it time to implement a hemorheology passport in sickle cell disease?

Blood cells, molecules & diseases·2026
Same journal

From blood viscosity to a hemorheology passport: Making sickle-cell monitoring clinically actionable.

Blood cells, molecules & diseases·2026
Same journal

A real-world analysis of polycythemia vera at two comprehensive cancer centers in Cali, Colombia.

Blood cells, molecules & diseases·2026
Same journal

Sickle Cell Disease: Can genetic variability influence pregnancy outcomes?

Blood cells, molecules & diseases·2026
See all related articles

Understanding the ATM gene

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • Cellular DNA damage response pathways are crucial for maintaining genomic stability.
  • Studies of human cancer susceptibility syndromes have illuminated DNA damage response mechanisms.
  • Ataxia telangiectasia is a cancer-prone disorder linked to mutations in the ATM gene.

Purpose of the Study:

  • To elucidate the molecular controls of cellular responses to DNA damage.
  • To explore the role of ATM (ataxia telangiectasia mutated) protein kinase in DNA double-strand break responses.
  • To discuss the therapeutic potential of modulating ATM activity in various diseases.

Main Methods:

  • Review of existing literature on DNA damage response pathways.
  • Analysis of insights gained from studying human cancer susceptibility syndromes.

Related Experiment Videos

  • Discussion of the function of ATM protein kinase.
  • Main Results:

    • ATM is a central mediator of cellular responses to DNA double-strand breaks.
    • ATM pathway modulation offers potential therapeutic strategies.
    • Inhibitors of ATM may sensitize cells to chemotherapy or radiation and possess anti-neoplastic effects.
    • Activators of ATM could enhance cellular responses to oxidative stress.

    Conclusions:

    • ATM plays a pivotal role in DNA damage response.
    • Targeting the ATM pathway presents opportunities for novel cancer therapies.
    • ATM modulation may have broader applications in treating diseases like metabolic syndrome.